This week Research.com published their annual, worldwide research rankings of scientists across all scientific specialities. We are incredibly proud that Professor Cyrus Cooper, Director and Professor of Rheumatology, MRC Lifecourse Epidemiology Centre, University of Southampton, featured as a clear global leader in medicine.
Professor Cooper received a Best Scientist Award, ranking 44th for all scientists from any discipline globally, and 1st in the field of Medicine in the United Kingdom.
The award recognises Professor Cooper’s substantial body of work including nearly 2400 research outputs and 300,000 citations. It highlights the world leading contribution Professor Cooper has made to the scientific literature on the global burden of disease, osteoporosis and rheumatic disorders and pioneering clinical studies on the developmental origins of peak bone mass.
“I am delighted to receive this award, which is recognition of the immense dedication and hard work of so many colleagues and collaborators in Southampton, the UK and across the world.”
Professor Cooper
Cyrus Cooper, OBE, DL, FMedSci is Professor of Rheumatology and Director of the MRC Lifecourse Epidemiology Centre; Vice-Dean of the Faculty of Medicine at the University of Southampton; and Professor of Epidemiology at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford.
He leads an internationally competitive programme of research into the epidemiology of musculoskeletal disorders, most notably osteoporosis.
He is President of the International Osteoporosis Foundation; a Fellow of the Academy of Medical Sciences; an emeritus NIHR Senior Investigator; and Associate Editor of Osteoporosis International. He has previously served as Chair of the Scientific Advisors Committee, International Osteoporosis Foundation; Chair, MRC Population Health Sciences Research Network; Chair of the Royal Osteoporosis Society of Great Britain; past-President of the Bone Research Society of Great Britain; and has worked on numerous Department of Health, European Community and World Health Organisation committees and working groups. In 2015, he was awarded an OBE for services to medical research.
Launched in July 2021, the MRC Lifecourse Epidemiology Centre is a flagship MRC investment in musculoskeletal epidemiology, evolved from the forerunning MRC Lifecourse Epidemiology Unit. Its mission is to use lifecourse epidemiological methods to reduce the population burden of chronic musculoskeletal disease and disability, focused principally on osteoporosis, osteoarthritis and sarcopenia.
